Inder Sehgal

1.8k total citations
45 papers, 1.5k citations indexed

About

Inder Sehgal is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Inder Sehgal has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Inder Sehgal's work include Protease and Inhibitor Mechanisms (12 papers), Prostate Cancer Treatment and Research (9 papers) and Virus-based gene therapy research (4 papers). Inder Sehgal is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Prostate Cancer Treatment and Research (9 papers) and Virus-based gene therapy research (4 papers). Inder Sehgal collaborates with scholars based in United States, Spain and France. Inder Sehgal's co-authors include Timothy C. Thompson, Garth Powis, Guang Yang, Nita J. Maihle, Mark R. Pittelkow, Joseph Francis, Martha Sibrian‐Vazquez, Robert T. Abraham, J. Paul Secrist and Terry L. Timme and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Inder Sehgal

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inder Sehgal United States 19 807 482 367 304 287 45 1.5k
Yun K. Hom United States 14 897 1.1× 461 1.0× 204 0.6× 277 0.9× 276 1.0× 25 1.6k
Daisuke Sano Japan 24 944 1.2× 822 1.7× 410 1.1× 418 1.4× 94 0.3× 99 2.2k
Chunhui Di United States 18 1.2k 1.4× 440 0.9× 353 1.0× 191 0.6× 136 0.5× 26 2.0k
Ryan D. Roberts United States 21 917 1.1× 577 1.2× 509 1.4× 453 1.5× 123 0.4× 57 1.8k
Neveen Said United States 24 803 1.0× 491 1.0× 397 1.1× 132 0.4× 91 0.3× 36 1.8k
Steven D. Mason United States 6 458 0.6× 320 0.7× 384 1.0× 157 0.5× 171 0.6× 9 1.0k
Aiping Luo China 29 1.8k 2.2× 598 1.2× 998 2.7× 243 0.8× 95 0.3× 66 2.5k
Ester Sànchez‐Tilló Spain 24 1.9k 2.4× 879 1.8× 601 1.6× 204 0.7× 169 0.6× 34 2.9k
Cynthia D. Branch United States 21 928 1.1× 756 1.6× 178 0.5× 126 0.4× 615 2.1× 28 1.7k
Kiyoko Yoshioka Japan 23 1.6k 1.9× 693 1.4× 339 0.9× 313 1.0× 118 0.4× 38 2.4k

Countries citing papers authored by Inder Sehgal

Since Specialization
Citations

This map shows the geographic impact of Inder Sehgal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inder Sehgal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inder Sehgal more than expected).

Fields of papers citing papers by Inder Sehgal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inder Sehgal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inder Sehgal. The network helps show where Inder Sehgal may publish in the future.

Co-authorship network of co-authors of Inder Sehgal

This figure shows the co-authorship network connecting the top 25 collaborators of Inder Sehgal. A scholar is included among the top collaborators of Inder Sehgal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inder Sehgal. Inder Sehgal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sehgal, Inder, et al.. (2024). A Comparison of Currently Approved Small Interfering RNA (siRNA) Medications to Alternative Treatments by Costs, Indications, and Medicaid Coverage. SHILAP Revista de lepidopterología. 12(2). 58–58. 14 indexed citations
2.
Sehgal, Inder. (2023). Outlook on Common U.S. Health Care Occupations: Benefits, Costs and Future Trends. Creative Education. 14(1). 41–53. 2 indexed citations
3.
Sehgal, Inder. (2023). Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations. Frontiers in Endocrinology. 14. 1184024–1184024. 3 indexed citations
4.
Sehgal, Inder, et al.. (2016). Potential adverse effects of long term use of Proton Pump Inhibitors. SHILAP Revista de lepidopterología. 2(3). 1 indexed citations
5.
Sehgal, Inder, et al.. (2016). Use of SkypeTM sessions with top cancer trial physicians to bring Interprofessional Education (IPE) into a didactic oncology course. Currents in Pharmacy Teaching and Learning. 8(3). 346–352. 3 indexed citations
6.
7.
Hasanuzzaman, Md, Robert Kutner, Siamak Agha‐Mohammadi, Jakob Reiser, & Inder Sehgal. (2007). A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines. Molecular Cancer. 6(1). 34–34. 13 indexed citations
8.
Sehgal, Inder, et al.. (2006). Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis.. Cancer Cell International. 6(1). 21–21. 9 indexed citations
9.
Paulsen, Daniel B., et al.. (2006). Immunohistochemical staining of urokinase plasminogen activator-like and urokinase plasminogen activator receptor-like proteins in the urinary tract of healthy dogs. American Journal of Veterinary Research. 67(9). 1628–1634. 6 indexed citations
10.
Hasanuzzaman, Md, et al.. (2006). The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells. Molecular Cancer. 5(1). 21–21. 31 indexed citations
11.
Kelley, Laura A., et al.. (2004). Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis. World Journal of Urology. 22(1). 67–71. 18 indexed citations
12.
Potti, Anil & Inder Sehgal. (2004). Exposure to pesticides increases levels of uPA and uPAR in pre-malignant human prostate cells. Environmental Toxicology and Pharmacology. 19(2). 215–219. 4 indexed citations
13.
Sehgal, Inder, et al.. (2003). Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts. Prostate Cancer and Prostatic Diseases. 6(2). 148–153. 10 indexed citations
14.
15.
Griffith, Thomas S., Jianjun Paul Tian, Julie Ritchey, et al.. (2001). Inhibition of Murine Prostate Tumor Growth and Activation of Immunoregulatory Cells With Recombinant Canarypox Viruses. JNCI Journal of the National Cancer Institute. 93(13). 998–1007. 26 indexed citations
16.
Timme, Terry L., Sang H. Park, Dov Kadmon, et al.. (2000). Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression. Clinical & Experimental Metastasis. 18(5). 429–438. 29 indexed citations
17.
Sehgal, Inder & Timothy C. Thompson. (1999). Novel Regulation of Type IV Collagenase (Matrix Metalloproteinase-9 and -2) Activities by Transforming Growth Factor-β1 in Human Prostate Cancer Cell Lines. Molecular Biology of the Cell. 10(2). 407–416. 146 indexed citations
18.
Eastham, James A., Inder Sehgal, Guang Yang, et al.. (1996). Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models. Human Gene Therapy. 7(4). 515–523. 134 indexed citations
19.
Yoshida, Kumi, et al.. (1995). Progression to androgen insensitivity in a novelin vitro mouse model for prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. 52(5). 403–413. 97 indexed citations
20.
Sehgal, Inder, et al.. (1994). Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.. Molecular Biology of the Cell. 5(3). 339–347. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun K. Hom Breakdown of academic impact, for papers by Daisuke Sano Breakdown of academic impact, for papers by Chunhui Di Breakdown of academic impact, for papers by Ryan D. Roberts Breakdown of academic impact, for papers by Neveen Said Breakdown of academic impact, for papers by Steven D. Mason Breakdown of academic impact, for papers by Aiping Luo Breakdown of academic impact, for papers by Ester Sànchez‐Tilló Breakdown of academic impact, for papers by Cynthia D. Branch Breakdown of academic impact, for papers by Kiyoko Yoshioka
Rankless by CCL
2026